Literature DB >> 9679039

The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy.

D Claeys1, G Faller, B J Appelmelk, R Negrini, T Kirchner.   

Abstract

BACKGROUND & AIMS: A subgroup of Helicobacter pylori-infected patients develops autoantibodies to gastric parietal cell canaliculi. The aim of this study was to define the unknown autoantigen.
METHODS: We screened 72 H. pylori-infected patients, 5 patients with autoimmune gastritis, and 36 healthy controls for immunoglobulin G autoantibodies to canaliculi by immunohistochemistry. The antigen specificity was determined by immunoprecipitation of the murine gastric H+,K+-adenosine triphosphatase (H+,K+-ATPase) expressed in oocytes and by immunoblotting on human gastric membranes from the body mucosa.
RESULTS: Autoantibodies specific for the conformational peptides of the H+,K+-ATPase were detected in 3% (1/36) of controls, in all patients with autoimmune gastritis (5/5), in 25% (18/72) of H. pylori-infected patients, and in 47% (15/32) of the infected patients with anticanalicular autoantibodies. No other major autoantigen was identified. Atrophy in the gastric body mucosa was found in 60% (9/15) of infected patients with both anticanalicular and anti-H+,K+-ATPase antibodies, but only in 13% (5/37) of infected patients lacking both autoantibodies (P < 0.01).
CONCLUSIONS: The gastric H+,K+-ATPase is a major autoantigen in H. pylori-associated antigastric autoimmunity. Thus, anti-H+,K+-ATPase autoantibodies, which are closely linked to classical autoimmune gastritis, are also significant indicators for body mucosa atrophy in chronic H. pylori gastritis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679039     DOI: 10.1016/s0016-5085(98)70200-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  46 in total

1.  Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia.

Authors:  M F Dixon
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

2.  Relationship of anti-Lewis x and anti-Lewis y antibodies in serum samples from gastric cancer and chronic gastritis patients to Helicobacter pylori-mediated autoimmunity.

Authors:  M A Heneghan; C F McCarthy; D Janulaityte; A P Moran
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Host Lewis phenotype-dependent Helicobacter pylori Lewis antigen expression in rhesus monkeys.

Authors:  Hans-Peter Wirth; Manqiao Yang; Edgardo Sanabria-Valentín; Douglas E Berg; André Dubois; Martin J Blaser
Journal:  FASEB J       Date:  2006-05-23       Impact factor: 5.191

Review 4.  Endoscopic diagnosis and management of type I neuroendocrine tumors.

Authors:  Yuichi Sato
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

5.  Immune thrombocytopenic purpura and infections.

Authors:  Antonio Ponzetto; Natale Figura; Giulia Fiorini
Journal:  Intern Emerg Med       Date:  2018-07-20       Impact factor: 3.397

Review 6.  Clinical features and management of type I gastric carcinoids.

Authors:  Yuichi Sato
Journal:  Clin J Gastroenterol       Date:  2014-09-17

7.  Inhibitory effects of Helicobacter pylori infection on murine autoimmune gastritis.

Authors:  M Ohana; K Okazaki; C Oshima; K Kawasaki; T Fukui; H Tamaki; M Matsuura; M Asada; T Nishi; K Uchida; S Uose; H Nakase; M Iwano; Y Matsushima; H Hiai; T Chiba
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

Review 8.  Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma.

Authors:  Mathijs P Bergman; Mario M D'Elios
Journal:  J Biomed Biotechnol       Date:  2010-06-22

Review 9.  Helicobacter pylori infection and micronutrient deficiencies.

Authors:  Javed Yakoob; Wasim Jafri; Shahab Abid
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

Review 10.  Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology.

Authors:  P G Falk; L V Hooper; T Midtvedt; J I Gordon
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.